home home contact us contact us how to reach us how to reach us sitemap sitemap
search
 
 
DRUG DISCOVERY PHASES
Target Identification and Validation
Finding Hits
Lead Discovery
Lead Optimization
Clinical Candidate Assessment
 
 
Our approaches to finding hits against targets of interest are centred on efficient utilization of available data, utilizing available active site information and/or known ligand structures as shown below.

Focussed compound arrays are thus used to generate hit compounds suitable for initial exploration of targets of interest.

All compounds are profiled against a selection of in vitro physicochemical and ADMET screens, such as solubility, metabolic stability, and passive permeability, to ensure that all compounds can be progressed simultaneously for biological and molecular property optimization.

Early stage screening of all compounds through physicochemical and ADMET screens will afford a wide chemical space for data-mining and in silico approaches and help development of models and experience for ADMET properties.
 



 
|  Privacy Policy  |   © 2008 - Siena Biotech ®